Leniolisib Gets Priority Review for Activated Phosphoinositide 3-Kinase Delta Syndrome By Brian Park, PharmD Publish Date September 28, 2022
Chloride Ion Channel Inhibitor Designated Orphan Drug for Myasthenia Gravis By Brian Park, PharmD Publish Date September 27, 2022
Roflumilast Foam Effective for Scalp, Body Psoriasis in Phase 3 Trial By Brian Park, PharmD Publish Date September 26, 2022
Pfizer, BioNTech Seek to Extend Authorization for Omicron-Adapted Booster to Children By Brian Park, PharmD Publish Date September 26, 2022
FDA Panel Votes on Microbiota-Based Enema Therapy for Recurrent C. Difficile Infection By Brian Park, PharmD Publish Date September 23, 2022
Rezafungin Gets Priority Review for Candidemia, Invasive Candidiasis By Brian Park, PharmD Publish Date September 21, 2022
Tucatinib + Trastuzumab Granted Priority Review for HER2-Positive Metastatic Colorectal Cancer By Brian Park, PharmD Publish Date September 20, 2022
Pentavalent Meningococcal Vaccine Meets All Endpoints in Phase 3 Trial By Brian Park, PharmD Publish Date September 16, 2022
Trial Evaluating Pfizer’s Quadrivalent mRNA Influenza Vaccine Begins By Brian Park, PharmD Publish Date September 14, 2022
Oral CDK7 Inhibitor Granted Orphan Drug Status for Pancreatic Cancer By Brian Park, PharmD Publish Date September 14, 2022
Aripiprazole 2-Month Under Review for Schizophrenia, Bipolar I Disorder By Brian Park, PharmD Publish Date September 13, 2022
FDA Panel Meeting Scheduled to Discuss Rx-to-OTC Switch of Oral Contraceptive Opill By Brian Park, PharmD Publish Date September 13, 2022
FDA to Review Velmanase Alfa for Alpha-Mannosidosis By Brian Park, PharmD Publish Date September 12, 2022
Trofinetide Gets Priority Review for Rett Syndrome By Brian Park, PharmD Publish Date September 12, 2022
FDA Panel Votes in Favor of Fixed-Dose Combination Therapy for ALS By Brian Park, PharmD Publish Date September 8, 2022
Maternal Vaccine Candidate for GBS Prevention in Infants Gets Breakthrough Tx Status By Brian Park, PharmD Publish Date September 7, 2022
Study Shows Linaclotide Beneficial for Pediatric Functional Constipation By Brian Park, PharmD Publish Date September 7, 2022
FDA to Review Perfluorohexyloctane Ophthalmic Solution for Dry Eye Disease By Brian Park, PharmD Publish Date September 7, 2022
